Nasogastric Tube Market Trends

Growth Drivers

• Higher Number of ICU Admissions – The people admitted to ICU, are in severe condition and face difficulties in consuming medicines orally. Nasogastric tubes are used to administer these medicines. In the United States, total non-COVID-19 admissions had risen to 16 percent of pre-pandemic baseline volume by late June/early July 2020.
• Increasing Prevalence of Chronic Diseases–In certain chronic diseases, such as pancreatic disorders or conditions with excessive fluid accumulation in the abdomen, nasogastric tubes can be used to drain excess fluid or prevent aspiration. By draining fluid from the stomach or preventing its reflux into the lungs, nasogastric tubes can help manage symptoms, reduce the risk of complications, and improve the patient’s life. According to the American Cancer Society's projections for pancreatic cancer in the United States in 2023, around 64,050 persons are anticipated to be diagnosed.
• Higher Adoption of Enteral Feeding– Nasogastric tubes provide a relatively simple and non-invasive method for enteral feeding in the ICU. They are a temporary solution and are easier to insert. Around 20% of children under the age of 18 are tube fed in America, and there are over 350 conditions that can need children to need nourishment using tube feeding.

    Challenges

• Infection Caused by the Tube – Nasogastric tubes, being invasive devices, pose a risk of infection. Improper insertion, inadequate maintenance, or prolonged use of the tube can increase the risk of infection, such as bloodstream infections, and pneumonia. Moreover, it can also cause nasal and sinus problems, such as nasal congestion, rhinitis, or sinusitis.

• Availability and Adoption of Alternative Enteral Access Methods
• Lack of Reimbursement Policies